Taxanes in Hormone‐Refractory Prostate Cancer

This publication has 6 references indexed in Scilit:

• Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer
  Journal of Clinical Oncology, 1999
• Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1999
• Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma
  Annals of Oncology, 1999
• Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.
  Journal of Clinical Oncology, 1997
• Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group
  Cancer, 1993
• Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
  Journal of Clinical Oncology, 1985